New York, NY, April 16, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “Biopharmaceutical Excipients Market By Product (Carbohydrates, Solubilizers & Surfactants/Emulsifiers, Polyols, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”.

“According to the research report, the global Biopharmaceutical Excipients Market was estimated at USD 1.94 Billion in 2019 and is expected to reach USD 3.07 Billion by 2026. The global Biopharmaceutical Excipients Market is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2019 to 2026”.

Biopharmaceutical Excipients Market: Overview and Definition

Biopharmaceuticals excipients are inactive substances. These are used as carriers excluding medicinal properties when combined with pharmaceutical ingredients to create a formulation with a longer shelf life. As biopharmaceutical molecules are unstable, a specific combination of excipients is necessary to improve the formulation’s stability. These substances have properties that enable them to change the color, binding ability, taste, elegancy, and release rate of the active pharmaceutical ingredient depending on the need. Excipients and active pharmaceutical medications are needed in any biopharmaceutical formulation. Binding agents, co-processed excipients, emulsifier agents, carrier agents, diluent excipients, and other stabilizing compounds are some of the most common uses for excipients.

Request Your Free Sample Report of Biopharmaceutical Excipients Market @                            

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 190+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of table & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Key Questions Answered in this Report

1) What were the pre and post-business impacts of COVID-19 on the Biopharmaceutical Excipients Market?

2) What is the market size, share of the Biopharmaceutical Excipients Market?

3) Who are the top market players in Biopharmaceutical Excipients Market?

4) What will be the future market of the Biopharmaceutical Excipients Market?

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2026
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
  • Competitive Landscape – Top key vendors and other prominent vendors

Enquire more about this report before purchase @                        

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Biopharmaceutical Excipients Market: Industry Major Market Players

  • Evonik Industries AG
  • Associated British Foods plc
  • Signet Excipients Pvt. Ltd (IMCD)
  • Clariant
  • Spectrum Chemical Manufacturing Corp.
  • Merck KGaA
  • Roquette Frères
  • Sigachi Industries Limited

To know an additional revised 2020 list of market players, request a sample report:     

With advances in the field of pharmaceutical manufacturing, the global biopharmaceutical excipients market is expected to evolve. Biopharmaceutical excipients aren’t active drugs, but they’re important in the development of a variety of drugs. The action of biopharmaceutical excipients during the healing phase enhances the tasks of the active drugs, and this aspect has contributed to their popularity. Within the pharmaceutical industry, the use of biopharmaceutical excipients is a strategic operation, and this is also a key factor in terms of market development.

The use of biopharmaceutical excipients is one such nascent technology that has made strides in the field of drug delivery technologies. As a result, it is reasonable to forecast that the global biopharmaceutical excipients market will develop at a healthy pace in the coming years.

The global biopharmaceutical excipients market’s investment portfolio is projected to increase in the coming years. This is primarily due to the nature of streamlined pharmaceutical production and the medical discharge industry. Medical practitioners and physicians have recognized the role of biopharmaceutical excipients in the healing process. In recent years, this aspect has been a significant driver of demand in the global biopharmaceutical excipients industry. A development that has helped market growth is the presence of multiple distribution channels for pharmaceutical products.

Directly Purchase a copy of the report with TOC @

Surge In The Advent Of Biopharmaceutical Excipients Will Fuel The Market Growth

Increased researches on the application of existing excipients that are compatible with large molecules are expected to aid the industry’s growth. Moreover, an increase in the production of functional excipients is attributing to the market growth. For example, DuPont has created an excipient, which is a surfactant that is claimed to be more effective and stable than other products available in the industry around the world. The FM 1000’s benefit as a surfactant is said to double or even triple the shelf life of biologics.

The increased demand for large molecule growth would drive the biopharmaceutical excipients market in the near future. The market is expected to benefit from a sharp increase in the regulatory environment for the production of biosimilars as a result of the parameter that shows it to be a better alternative. However, the cost of excipients could restrict the industry’s growth during the forecast period. Furthermore, excipients for biopharmaceuticals are now being formulated in such a way that they can enter an interface and stabilize the formulation. Surfactants have been grown to the point that they provide an interface between the solutions, which consists of the biologic and the syringe wall, or even an air pocket. It’s also indicated that it gets to the interface 10 to 100 times quicker than the incumbent surfactant’s equivalent concentration. The advantages of novel excipients, which produce better results than previously developed products, are expected to aid industrial growth in the near future.

Request Customized Copy of Report @

(We customize your report according to your research need. Ask our sales team for report customization.)

COVID-19 Impact on the Global Biopharmaceutical Excipients Market

The spread of an infectious disease that caused a major respiratory problem resulted in a surge in demand for macromolecules for treatment. The rising demand for such macromolecules necessitates biopharmaceutical excipients to improve stability and shelf life, which is expected to aid market growth in the near future. The pandemic has prompted major players to focus their efforts on developing genetically modified molecules for improved care of Covid-19 patients, which is expected to increase the use of pharmaceutical excipients in the immediate future. Furthermore, the regulatory environment has aided researchers with additional incentives such as tax exemptions, which would assist key leaders in maximizing revenue in the coming years. The pharmaceutical and biotechnology industries are currently in a state of crisis. The growth in demand for longer-lasting medications, on the other hand, would help the industry gain more market share in the coming years.

To Know COVID-19 Pre and Post Business Impact Analysis, Request a Free Report PDF Brochure:

Europe Region Dominates the Global Biopharmaceutical Excipients Market

Owing to the expiration of blockbuster drug patents in the coming years, many European countries are concentrating their attention on the generics market. As a result, the European region’s generics market is projected to expand significantly during the forecast period, boosting demand for pharmaceutical excipients. Increased government efforts to reduce drug prices in countries like Germany, Italy and Spain are expected to boost the demand for generic drugs in these countries. The aforementioned reasons, combined with increased investments in biologics and innovative dosage forms production, would increase demand for novel excipients, assisting the growth of the European pharmaceutical excipients industry.

Browse the full “Biopharmaceutical Excipients Market By Product (Carbohydrates, Solubilizers & Surfactants/Emulsifiers, Polyols, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at

The global biopharmaceutical excipients market is segmented as follows:

By Product:

  • Carbohydrates
  • Solubilizers & Surfactants/Emulsifiers
  • Polyols
  • Others

Related Reports:

Active Pharmaceutical Ingredient Market:

Erectile Dysfunction Drugs Market:

Ethidium Bromide Market:

Antimalarial Drugs Market:

Pharmacokinetics Services Market:  

About Facts & Factors (FnF Research):

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us LinkedIn:

Follow Us Twitter:

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email: [email protected]



Primary Logo

Source News